These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 364934)

  • 1. [Application of the discriminating analysis to the longitudinal analysis of psychometric questionnaires and the evaluation of psychothropic drugs].
    Cuadras CM; Roméu J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(6):653-6. PubMed ID: 364934
    [No Abstract]   [Full Text] [Related]  

  • 2. Rating scales in psychopharmacology. Statistical aspects.
    Bech P
    Acta Psychiatr Belg; 1988; 88(4):291-302. PubMed ID: 3078609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
    Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discrimination: methods for drug characterization and classification.
    Bigelow GE; Preston KL
    NIDA Res Monogr; 1989; 92():101-22. PubMed ID: 2512490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Critical review of psychometric tests].
    de Rotrou J; Moulin F
    Therapie; 1993; 48(3):195-9. PubMed ID: 8140557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of psychotropic drugs].
    Nieto D
    Bol Estud Med Biol; 1974; Suppl 1():309-17. PubMed ID: 4619018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ethical and legal problems in first clinical trials of psychotropic drugs (author's transl)].
    Helmchen H
    Arzneimittelforschung; 1978; 28(8):1253-6. PubMed ID: 380572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.
    Saletu B; Grünberger J; Flener R; Linzmayer L; Sieroslawski H
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):810-21. PubMed ID: 827426
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of choice procedures for assessing the reinforcing properties of drugs in humans.
    Johanson CE; de Wit H
    NIDA Res Monogr; 1989; 92():171-210. PubMed ID: 2512492
    [No Abstract]   [Full Text] [Related]  

  • 10. Social functioning and the treatment of depression.
    Weissman MM
    J Clin Psychiatry; 2000; 61 Suppl 1():33-8. PubMed ID: 10703761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the relevance of clinical measurements testing psychogeriatric drugs (author's transl)].
    Heimann H
    Arzneimittelforschung; 1980; 30(8):1189-91. PubMed ID: 7192134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual NCDEU Meeting (1982)--abridged proceedings. New Clinical Drug Evaluation Unit, National Institute of Mental Health.
    Psychopharmacol Bull; 1983; 19(1):23-140. PubMed ID: 6338549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of drug testing with the help of psychometric methods. Possibilities and problems].
    Oswald WD
    Med Welt; 1981 Aug; 32(34):1225-31. PubMed ID: 7024711
    [No Abstract]   [Full Text] [Related]  

  • 14. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977].
    Heimann H
    Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B; Angst J
    Arzneimittelforschung; 1978; 28(8):1257-9. PubMed ID: 380573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of the clinical evaluation of psychotropic drugs].
    Moizeszowicz J
    Acta Psiquiatr Psicol Am Lat; 1975 Mar; 21(1):41-51. PubMed ID: 1163268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.
    Ereshefsky L; Jann MW; Saklad SR; Davis CM
    J Clin Psychiatry; 1986 Sep; 47 Suppl():6-15. PubMed ID: 3528134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems in clinical testing of a psychotropic substance examplified by L-5-HTP-ester (author's transl)].
    Gastpar M; Pühringer W; Graw P; Wirz-Justice A; Lacoste V
    Arzneimittelforschung; 1978; 28(8):1282-3. PubMed ID: 380576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings: Clinical trials: Methodology versus practice? - An attempted Compromise (author's transl)].
    Abt K; Baumann U; Debus G; Ferner U; Heimann H; Müller-Oerlinghausen B; Woggon B
    Arzneimittelforschung; 1976; 26(6):1025-6. PubMed ID: 786306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.